Diagnostics Platform Coming to Your Smartphone, Antigen Discovery Inc. Reveals

8/16/2012 8:01:10 AM

Antigen Discovery was awarded a $600,000 Phase I Small Business Innovation and Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) to fund a collaborative project focused on developing a handheld, point-of-care microfluidic immunodiagnostics platform for detecting infectious diseases during mass disasters, natural disease outbreaks, or bioterrorist threats. Announcement of the grant comes just a couple of days after Antigen confirmed being awarded $2.5 million by the NIAID to continue its work on the development of Plasmodium parasite biomarkers that indicate response to malaria vaccine candidates in development by Sanaria.

Read at News Release

Read Article at

Related Companies

News Categories

• News Release

• Antigen Discovery Inc.

• Diagnostics

• Medical Dev. & Diag. - Research